(Q46105584)

19 December 2017

title

Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction (English)

1 reference

19 December 2017

1 reference

Robert V DiGregorio

1

1 reference

19 December 2017

Yanina Pasikhova

series ordinal

2

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

19 December 2017

published in

Pharmacotherapy

1 reference

19 December 2017

volume

29

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

352-356

1 reference

19 December 2017

Sitagliptin: a novel drug for the treatment of type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.352

Standards of medical care in diabetes--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.352

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.352

Rhabdomyolysis and HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.352

Exertional rhabdomyolysis: early recognition is key.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.352

Rhabdomyolysis in a patient with hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.352

The effect of corticosteroid injection for trigger finger on blood glucose level in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.352

Outcomes in 45 patients with statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.352

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.3.352

1 reference

19 December 2017

1 reference

19 December 2017